Go Pro
NASDAQ:MRAI

Marpai (MRAI) Stock Price, News & Analysis

Marpai logo
$2.15 -0.08 (-3.59%)
As of 03:56 PM Eastern

About Marpai Stock (NASDAQ:MRAI)

Advanced

Key Stats

Today's Range
$2.10
$2.20
50-Day Range
$0.43
$2.37
52-Week Range
$0.22
$2.50
Volume
100,322 shs
Average Volume
71,271 shs
Market Capitalization
$57.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Marpai Inc. is a technology-driven healthcare benefits management company that leverages data analytics and artificial intelligence to optimize health outcomes and control costs for self-insured employers. Its flagship Marpai Health Platform integrates personalized care pathways, advanced member engagement tools and real-time claims analytics. By combining machine learning models with clinical expertise, Marpai identifies risk patterns early and guides members toward cost-effective, high-quality care.

Marpai’s suite of services encompasses underwriting, care coordination, pharmacy benefits management and virtual health coaching, all delivered through a unified digital interface. The platform offers proactive notifications, personalized recommendations and continuous support to help members navigate complex healthcare decisions. Employers using Marpai’s solutions gain greater visibility into cost drivers and can realize measurable reductions in total medical expenses.

Founded by a team of healthcare and technology professionals, Marpai is headquartered in the United States and primarily serves mid-sized to large self-insured organizations across diverse industries. The company’s data-driven approach underpins sustainable cost management and enhances member satisfaction through transparent pricing, targeted interventions and evidence-based care pathways.

Marpai began trading on the NASDAQ under the symbol MRAI, marking its transition to a public company committed to advancing innovation in digital health. While focused on the U.S. market, Marpai continues to explore strategic partnerships and product enhancements designed to expand its capabilities and refine its precision health insights.

AI Generated. May Contain Errors.

Receive MRAI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Marpai and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MRAI Stock News Headlines

The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel
See More Headlines

MRAI Stock Analysis - Frequently Asked Questions

Marpai's stock was trading at $0.6310 at the beginning of 2026. Since then, MRAI stock has increased by 240.7% and is now trading at $2.15.

Marpai, Inc. (NASDAQ:MRAI) released its quarterly earnings results on Thursday, May, 9th. The company reported ($0.46) earnings per share (EPS) for the quarter. The business earned $7.39 million during the quarter.

Marpai shares reverse split on Thursday, June 29th 2023.The 1-4 reverse split was announced on Thursday, June 29th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 29th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

Marpai (MRAI) raised $25 million in an IPO on Wednesday, October 27th 2021. The company issued 6,300,000 shares at $4.00 per share. ThinkEquity served as the underwriter for the IPO.

Shares of MRAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Marpai investors own include NVIDIA (NVDA), Meta Platforms (META), Snowflake (SNOW), iShares Core S&P 500 ETF (IVV), Tesla (TSLA), Airbnb (ABNB) and Allegion (ALLE).

Company Calendar

Last Earnings
5/09/2024
Today
8/03/2026
Next Earnings (Estimated)
8/12/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
N/A
Current Symbol
NASDAQ:MRAI
CIK
1844392
Fax
N/A
Employees
150
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.87)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$28.75 million
Net Margins
-85.70%
Pretax Margin
-86.66%
Return on Equity
N/A
Return on Assets
-100.23%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.82
Quick Ratio
0.82

Sales & Book Value

Annual Sales
$34.87 million
Price / Sales
1.66
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.72) per share
Price / Book
-1.25

Miscellaneous

Outstanding Shares
26,872,000
Free Float
5,605,000
Market Cap
$57.77 million
Optionable
No Data
Beta
4.92
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:MRAI) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners